Blar i Department of Biomedicine på emneord "NG2/CSPG4"
Viser treff 1-1 av 1
-
Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival
(Peer reviewed; Journal article, 2013-09-09)Glioblastoma (GBM) is the most malignant brain tumor where patients’ survival is only 14.6 months, despite multimodal therapy with debulking surgery, concurrent chemotherapy and radiotherapy. There is an urgent, unmet need ...